Investigators detected six commonly used antibiotics throughout the Dunga wetland system and associated drinking water. The compounds analyzed were amoxicillin trihydrate, ciprofloxacin, flucloxacillin, sulfamethoxazole, trimethoprim, and levofloxacin. Data indicated that sediment samples contained more detectable residues and higher concentrations than surface water samples. The two most prevalent compounds were ciprofloxacin and sulfamethoxazole. Reported maximum concentrations reached 3.4 ng L⁻1 in water and 3.7 ng kg⁻1 in sediment for these dominant agents. The study team observed that all six target antibiotics were present across the matrices sampled, demonstrating diffuse contamination within the wetland environment.
The authors sampled three longitudinal sections of the wetland—upper, middle, and lower—and obtained drinking water samples taken both before and after treatment at the Dunga treatment facility. They used solid-phase extraction for analyte isolation from water and sediment matrices, and they performed instrumental quantification by liquid chromatography–mass spectrometry. The abstract did not report exact sampling dates, numbers of samples per site, or method detection and quantitation limits; those specifics were not provided in the PubMed abstract. Still, the described workflow—sectional wetland sampling paired with treated drinking water monitoring and LC-MS analysis—allowed the investigators to compare distribution patterns across compartments and to evaluate treatment removal performance.
Treatment performance varied markedly by compound. The treatment system achieved a reported removal efficiency of 95% for amoxicillin trihydrate. By contrast, ciprofloxacin showed only a 6.4% reduction through the same treatment process. The study team concluded that conventional water treatment at this facility substantially reduces some antibiotics but is inadequate for effectively removing others. They attributed residual concentrations after treatment to limitations in standard treatment processes; the abstract did not specify the particular unit processes or operational parameters used at the treatment plant.
The investigators calculated human health hazard quotient values and found them to be several orders of magnitude below one. From that perspective, the data indicated no immediate non-carcinogenic human health risk under the exposure assumptions applied by the authors. However, the team also compared measured antibiotic levels with ecological selection benchmarks for resistance. They reported that ciprofloxacin concentrations exceeded the minimum selective concentration threshold linked to emergence and selection of antimicrobial resistance. This creates a potential long-term ecological and public health concern: even when human hazard quotients are low, environmental antibiotic levels can select for resistant organisms and propagate resistance determinants through wetland and downstream systems.
The authors recommended the adoption of enhanced wetland technologies within the Dunga Wetland ecosystem to improve removal efficiencies for antibiotic residues and other contaminants. They noted that conventional treatment systems failed to remove certain antibiotics effectively—ciprofloxacin being a key example—and that residual concentrations therefore persist in the environment and in treated drinking water.
Limitations reported or evident from the abstract include absence of detailed methodological parameters in the PubMed summary: the abstract did not provide specific sample sizes, sampling dates, or analytical limits of detection and quantification. It also did not list the specific unit treatment processes at the Dunga drinking water facility. Those missing details limit the ability to fully assess representativeness, temporal variability, and analytical sensitivity from the abstract alone. Follow-up work might address seasonal sampling, broader compound panels, and targeted evaluation of treatment-unit performance.
The study fills an information gap about antibiotic residues in Kenyan wetland systems but leaves several unanswered operational questions: which treatment stages (if any) are responsible for partial removal; how concentrations vary over seasons; and what the downstream microbiological effects are with respect to resistance gene prevalence. The authors called for technology upgrades to the wetland and water-treatment interfaces to reduce residual antibiotic loads and to mitigate selection pressure for antimicrobial resistance.